Blue Sky Alternative Investments Limited (ASX:BLA) is currently trading at a trailing P/E of 8.6x, which is lower than the industry average of 18.2x. While this makes BLA appear like a great stock to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
bluebird bio, Inc. BLUE announced that the FDA has granted priority review to the biologics license application (BLA) seeking approval for elivaldogene autotemcel (eli-cel, Lenti-D) to treat cerebral ...
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced the submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ...
+ Company announcements and prices are delayed by least 20 minutes. Prices are indicative only. DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds ...
+ Company announcements and prices are delayed by least 20 minutes. Prices are indicative only. DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results